Linda Elise Couëssurel Wüsthoff

  • Researcher; MD, PhD
  • +47 905 69 834

Psychiatrist, Community Medicine specialist

Affiliations:

Unit for Clinical Research on Addictions, Oslo University Hospital Health Trust, www.rusforsk.no
Norwegian Centre for Addiction Research, University of Oslo, www.seraf.uio.no

Senter for eliminasjon av hepatitt C (SELIHEP), Lovisenberg Diakonale sykehus

Research interests:

  • Comorbidity of substance use disorders and somatic illnesses
  • Comorbidity of substance use disorders and psychiatric illnesses
  • Harm reduction health services for people with substance use disorders

Projects:

Heroin-assisted treatment

Prevalence and symptom picture of covid-19 in people who use drugs in Oslo during the SARS-CoV-2 pandemic

Choice of medication in low threshold opioid agonist treatment. 

The interplay between substance use, health, and use of health care services in people who use drugs - AlcoTail – Workpackage 3

Prevalence and symptoms of covid-19 in people who use drugs in Oslo during the SARS-CoV-2 pandemic (finished)

Links:

Linda Wüsthoff (0000-0002-6808-8323) (orcid.org)

Linda Wüsthoff - Google Scholar

Linda Elise Couessurel Wüsthoff - Institute of Clinical Medicine (uio.no)

Linda Wüsthoff (researchgate.net)

Publications from ORCID (requires login)

 

Publications 2024

Gainullin M, Federico L, Røkke Osen J, Chaban V, Kared H, Alirezaylavasani A, Lund-Johansen F, Wildendahl G, Jacobsen JA, Sarwar Anjum H, Stratford R, Tennøe S, Malone B, Clancy T, Vaage JT, Henriksen K, Wüsthoff L, Munthe LA (2024)
People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination
Front Immunol, 14, 1235210
DOI 10.3389/fimmu.2023.1235210, PubMed 38299149

Melis F, Clausen T, Castel C, Dadras O, De Pirro S, Myklebust LH, Oldervoll A, Wüsthoff LE, Eide D (2024)
Patient Characteristics From Norway's First Heroin-Assisted Treatment Clinics
Subst Use Addctn J, 46 (1), 13-24
DOI 10.1177/29767342241271991, PubMed 39308161

Myklebust LH, Eide D, Arnevik EA, Dadras O, De Pirro S, Ellefsen R, Fadnes LT, Hesse M, Kvamme TL, Melis F, Oldervoll A, Thylstrup B, Wusthoff LEC, Clausen T (2024)
Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study
BMC Health Serv Res, 24 (1), 398
DOI 10.1186/s12913-024-10767-w, PubMed 38553691

Tjelta T, Bogstrand ST, Lerdal A, Wüsthoff LEC, Edvardsen HME, Johannessen A (2024)
Screening and Following Up Harmful Alcohol Use "… is Not Necessarily Your Primary Focus": A Qualitative Study Exploring Health Professionals' Experiences Addressing Harmful Alcohol Use in a Norwegian Hospital
J Multidiscip Healthc, 17, 5189-5198
DOI 10.2147/JMDH.S475750, PubMed 39558926

Wüsthoff LEC, Lund-Johansen F, Henriksen K, Wildendahl G, Jacobsen JA, Gomes L, Anjum HS, Barlinn R, Kran AB, Munthe LA, Vaage JT (2024)
Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies
Harm Reduct J, 21 (1), 120
DOI 10.1186/s12954-024-01023-9, PubMed 38890611

Publications 2023

Ellefsen R, Wüsthoff LEC, Arnevik EA (2023)
Patients' satisfaction with heroin-assisted treatment: a qualitative study
Harm Reduct J, 20 (1), 73
DOI 10.1186/s12954-023-00808-8, PubMed 37312181

Malme KB, Ulstein K, Finbråten AK, Wüsthoff LEC, Kielland KB, Hauge J, Dalgard O, Midgard H (2023)
Hepatitis C treatment uptake among people who inject drugs in Oslo, Norway: A registry-based study
Int J Drug Policy, 116, 104044
DOI 10.1016/j.drugpo.2023.104044, PubMed 37149914

Rognli EB, Dalsrud MK, Wüsthoff LEC, Arnevik EA (2023)
[Poor uptake of service provision at a drug-related emergency department – a qualitative study]
Tidsskr Nor Laegeforen, 143 (5)
DOI 10.4045/tidsskr.22.0471, PubMed 36987889

Publications 2021

Midgard H, Ulstein K, Backe Ø, Foshaug T, Sørli H, Vennesland K, Nilssen D, Dahl EH, Finbråten AK, Wüsthoff L, Dalgard O (2021)
Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway
Int J Drug Policy, 96, 103165
DOI 10.1016/j.drugpo.2021.103165, PubMed 33642182

Publications 2014

Wüsthoff LE, Waal H, Gråwe RW (2014)
The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and/or depression--a group randomized trial
BMC Psychiatry, 14, 67
DOI 10.1186/1471-244X-14-67, PubMed 24597469

Publications 2012

Wüsthoff LE, Waal H, Gråwe RW (2012)
When research meets reality-lessons learned from a pragmatic multisite group-randomized clinical trial on psychosocial interventions in the psychiatric and addiction field
Subst Abuse, 6, 95-106
DOI 10.4137/SART.S9245, PubMed 22933843

Publications 2011

Wüsthoff LE, Waal H, Ruud T, Gråwe RW (2011)
A cross-sectional study of patients with and without substance use disorders in Community Mental Health Centres
BMC Psychiatry, 11, 93
DOI 10.1186/1471-244X-11-93, PubMed 21605358

Publications 2010

Wüsthoff LE, Waal H, Ruud T, Røislien J, Gråwe RW (2010)
Identifying co-occurring substance use disorders in community mental health centres. Tailored approaches are needed
Nord J Psychiatry, 65 (1), 58-64
DOI 10.3109/08039488.2010.489954, PubMed 20507263

Publications 2008

Wüsthoff L, Havnes I, Gjersing L, Willersrud A (2008)
[Self-satisfied course leadership--seen from the other side]
Tidsskr Nor Laegeforen, 128 (19), 2224-5; author reply 2225
PubMed 18846152

Scroll to top